ABVC BioPharma, Inc. (ABVC)

0.9471 -0.05 (-5.29%) USD  |  NASDAQ  |  Sep 04, 16:00
0.9471 0.00 (0.00%) After-Hours: 19:51
More

ABVC BioPharma Cash and Short Term Investments (Annual) : 1.391M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ABVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2002. Start Trial.
Date Value
December 31, 2025 1.391M
December 31, 2024 0.9286M
December 31, 2023 0.7961M
December 31, 2022 1.468M
December 31, 2021 6.673M
December 31, 2020 5.001M
December 31, 2019 0.1604M
December 31, 2018 0.2428M
December 31, 2017 0.0933M
September 30, 2016 0.1735M
September 30, 2015 0.9948M
September 30, 2014 0.00
Date Value
September 30, 2013 0.0006M
September 30, 2012 0.0134M
September 30, 2011 0.0718M
September 30, 2010 0.0028M
September 30, 2009 0.00
September 30, 2008 0.9743M
September 30, 2007 0.8082M
September 30, 2006 0.7364M
September 30, 2005 0.0102M
December 31, 2004 0.0818M
December 31, 2003 0.1048M
December 31, 2002 0.0012M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Anika Therapeutics, Inc. 57.48M
Perspective Therapeutics, Inc. 144.74M
MiMedx Group, Inc. 166.12M
Abbott Laboratories 8.939B
AngioDynamics, Inc. 53.86M